Constrictive Pericarditis in the Presence of Remaining Remnants of a Left Ventricular Assist Device in a Heart

R Rivinius1, M Helmschrott1, V Koch1

  • 1Department of Cardiology, Angiology and Pneumology, University of Heidelberg, 69120 Heidelberg, Germany.

Insights

Constrictive pericarditis (CP) developed in a heart transplant patient due to a retained left ventricular assist device (LVAD) component. Surgical removal of the LVAD remnant resolved the CP, improving the patient's symptoms.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Transplantation Medicine

Background:

  • Constrictive pericarditis (CP) is a severe condition affecting the pericardium.
  • Heart transplantation (HTX) patients can develop various complications.
  • Retained foreign bodies after surgery are rare but can cause significant issues.

Purpose of the Study:

  • To report a unique case of constrictive pericarditis.
  • To highlight the role of a retained left ventricular assist device (LVAD) component as a cause of CP.
  • To describe the successful surgical management and outcomes.

Main Methods:

  • A 63-year-old male heart transplant recipient presented with dyspnea and fatigue.
  • Cardiac MRI incidentally detected a foreign body in the epicardial tissue.
  • Echocardiography and cardiac catheterization confirmed constrictive pericarditis.
  • Surgical removal of the foreign body (LVAD remnant) and pericardiectomy were performed.

Main Results:

  • A retained LVAD inflow pump connection was identified as the cause of CP.
  • Surgical removal of the LVAD remnant and pericardiectomy were successfully performed.
  • The patient experienced rapid symptom improvement and uneventful recovery.
  • Follow-up at 3 and 6 months showed stable clinical status and improved physical capacity.

Conclusions:

  • A retained LVAD component can lead to constrictive pericarditis in heart transplant recipients.
  • Surgical intervention for removal of the foreign body and pericardiectomy is effective.
  • Prompt diagnosis and management result in favorable patient outcomes and symptom resolution.

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
786
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
549
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
679
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
859
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
749
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
926